{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:45:25Z","timestamp":1761515125834,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.4158\/ep.7.6.480","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T21:05:09Z","timestamp":1365455109000},"page":"480-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acquired Immunodeficiency Syndrome-Related Insulin Resistance and Lipodystrophy: A Multifactorial Viral and Iatrogenic Condition"],"prefix":"10.1016","volume":"7","author":[{"given":"Tomoshige","family":"Kino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George P.","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.7.6.480_bb0005","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0891-5520(05)70136-7","article-title":"Antiretroviral therapy in the year 2000","volume":"14","author":"Tashima","year":"2000","journal-title":"Infect Dis Clin North Am."},{"key":"10.4158\/EP.7.6.480_bb0010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00126334-200012010-00003","article-title":"Multicenter review of protease inhibitors in 89 pregnancies","volume":"25","author":"Morris","year":"2000","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.4158\/EP.7.6.480_bb0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1369-5274(00)00131-4","article-title":"Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options","volume":"3","author":"Kaufmann","year":"2000","journal-title":"Curr Opin Microbiol."},{"key":"10.4158\/EP.7.6.480_bb0020","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0140-6736(00)02388-6","article-title":"Hit HIV-1 hard, but only when necessary","volume":"355","author":"Harrington","year":"2000","journal-title":"Lancet."},{"key":"10.4158\/EP.7.6.480_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(99)00068-6","article-title":"Antiretroviral therapy: state of the HAART","volume":"45","author":"Vella","year":"2000","journal-title":"Antiviral Res."},{"key":"10.4158\/EP.7.6.480_bb0030","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/sj.ijo.0801278","article-title":"The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes","volume":"24","author":"Chrousos","year":"2000","journal-title":"Int J Obes Relat Metab Disord."},{"key":"10.4158\/EP.7.6.480_bb0035","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(05)60295-4","article-title":"\u201cBuffalo hump\u201d in HIV-1 infection [letter]","volume":"352","author":"Stocker","year":"1998","journal-title":"Lancet."},{"key":"10.4158\/EP.7.6.480_bb0040","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(05)60294-2","article-title":"\u201cBuffalo hump\u201d in HIV-1 infection [letter]","volume":"352","author":"De Luca","year":"1998","journal-title":"Lancet."},{"key":"10.4158\/EP.7.6.480_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(05)60293-0","article-title":"\u201cBuffalo hump\u201d in HIV-1 infection [letter]","volume":"352","author":"Saint-Marc","year":"1998","journal-title":"Lancet."},{"key":"10.4158\/EP.7.6.480_bb0050","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"\u201cBuffalo hump\u201d in men with HIV-1 infection","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet."},{"key":"10.4158\/EP.7.6.480_bb0055","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/00002030-199911120-00007","article-title":"Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations","volume":"13","author":"Christeff","year":"1999","journal-title":"AIDS."},{"key":"10.4158\/EP.7.6.480_bb0060","first-page":"720","article-title":"\u201cBuffalo hump\u201d related to indinavir treatment [article in French]","volume":"126","author":"Dornier","year":"1999","journal-title":"Ann Dermatol Venereol."},{"key":"10.4158\/EP.7.6.480_bb0065","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/00126334-200010001-00002","article-title":"Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review","volume":"25","author":"Graham","year":"2000","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.4158\/EP.7.6.480_bb0070","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(00)02854-3","article-title":"Adverse effects of antiretroviral therapy","volume":"356","author":"Carr","year":"2000","journal-title":"Lancet."},{"key":"10.4158\/EP.7.6.480_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2165\/00002018-200023010-00004","article-title":"Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?","volume":"23","author":"Behrens","year":"2000","journal-title":"Drug Saf."},{"key":"10.4158\/EP.7.6.480_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1592\/phco.20.1.13.34667","article-title":"HIV-associated lipodystrophy syndrome","volume":"20","author":"Qaqish","year":"2000","journal-title":"Pharmacotherapy."},{"key":"10.4158\/EP.7.6.480_bb0085","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet."},{"key":"10.4158\/EP.7.6.480_bb0090","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0006-2952(00)00246-X","article-title":"Stimulation of vitamin A(1) acid signaling by the HIV protease inhibitor indinavir","volume":"59","author":"Lenhard","year":"2000","journal-title":"Biochem Pharmacol."},{"key":"10.4158\/EP.7.6.480_bb0095","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem."},{"key":"10.4158\/EP.7.6.480_bb0100","series-title":"Presented at the 6th European Conference on Clinical Aspects and Treatment of HIV Infection","article-title":"Nonactivity of hepatic lipase during treatment with ritonavir","author":"Jiminez-Exposito","year":"1997"},{"key":"10.4158\/EP.7.6.480_bb0105","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1210\/jcem.84.11.6234","article-title":"Inhibition of adipocyte differentiation by HIV protease inhibitors","volume":"84","author":"Zhang","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.7.6.480_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-3542(00)00102-9","article-title":"HIV protease inhibitors block adipogenesis and increase lipolysis in vitro","volume":"47","author":"Lenhard","year":"2000","journal-title":"Antiviral Res."},{"key":"10.4158\/EP.7.6.480_bb0115","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1097\/00002030-200011100-00007","article-title":"Ritonavir increases the level of active ADD-1\/SREBP-1 protein during adipogene-sis","volume":"14","author":"Nguyen","year":"2000","journal-title":"AIDS."},{"key":"10.4158\/EP.7.6.480_bb0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0140-6736(05)75347-2","article-title":"ApoE genotype and protease-inhibitor-associated hyperlipidaemia [letter]","volume":"354","author":"Behrens","year":"1999","journal-title":"Lancet."},{"issue":"5 Suppl","key":"10.4158\/EP.7.6.480_bb0125","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1067\/mai.2000.110163","article-title":"Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae","volume":"106","author":"Chrousos","year":"2000","journal-title":"J Allergy Clin Immunol."},{"key":"10.4158\/EP.7.6.480_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1086\/514638","article-title":"Pseudo-Cushing\u2019s syndrome in human immunodeficiency virus-infected patients","volume":"27","author":"Miller","year":"1998","journal-title":"Clin Infect Dis."},{"key":"10.4158\/EP.7.6.480_bb0135","series-title":"AIDS: Diagnosis, Treatment and Prevention","first-page":"45","article-title":"The molecular biology of HIV-1","author":"Pavlakis","year":"1996"},{"key":"10.4158\/EP.7.6.480_bb0140","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1210\/jcem.84.6.5740","article-title":"Endocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophy","volume":"84","author":"Yanovski","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.7.6.480_bb0145","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0960-9822(02)00676-0","article-title":"HIV-1, Vpr and the cell cycle","volume":"6","author":"Emerman","year":"1996","journal-title":"Curr Biol."},{"key":"10.4158\/EP.7.6.480_bb0150","doi-asserted-by":"crossref","first-page":"35209","DOI":"10.1074\/jbc.M005197200","article-title":"Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome","volume":"275","author":"Sawaya","year":"2000","journal-title":"J Biol Chem."},{"key":"10.4158\/EP.7.6.480_bb0155","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1128\/jvi.69.2.1243-1252.1995","article-title":"Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency","volume":"69","author":"Levy","year":"1995","journal-title":"J Virol."},{"key":"10.4158\/EP.7.6.480_bb0160","doi-asserted-by":"crossref","first-page":"32016","DOI":"10.1074\/jbc.M004044200","article-title":"Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest","volume":"275","author":"Henklein","year":"2000","journal-title":"J Biol Chem."},{"key":"10.4158\/EP.7.6.480_bb0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.189.1.51","article-title":"The HIV-1 virion-associated protein Vpr is a coac-tivator of the human glucocorticoid receptor","volume":"189","author":"Kino","year":"1999","journal-title":"J Exp Med."},{"key":"10.4158\/EP.7.6.480_bb0170","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1677\/joe.0.1690437","article-title":"Glucocorticoid and mineralocorticoid resistance\/hypersensitivity syndromes","volume":"169","author":"Kino","year":"2001","journal-title":"J Endocrinol."},{"key":"10.4158\/EP.7.6.480_bb0175","series-title":"Presented at the 82nd Annual Meeting of The Endocrine Society","article-title":"Chrousos GP. The human immunodeficiency virus type-1 accessory proteins Vpr and Tat both function as coregulators of the nuclear receptor signaling system","author":"Kino","year":"2000"},{"key":"10.4158\/EP.7.6.480_bb0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)80939-3","article-title":"A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA","volume":"92","author":"Wei","year":"1998","journal-title":"Cell."},{"key":"10.4158\/EP.7.6.480_bb0185","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1073\/pnas.91.2.664","article-title":"Tat-mediated delivery of het-erologous proteins into cells","volume":"91","author":"Fawell","year":"1994","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.4158\/EP.7.6.480_bb0190","series-title":"resented at the International Meeting of the Institute of Human Virology","article-title":"HIV-1 Vpr binds and inhibits PPAR-\u03b3: implications for HIV-associated insulin resistance and lipodystrophy","author":"Shrivastav","year":"2000"},{"key":"10.4158\/EP.7.6.480_bb0195","series-title":"Presented at the 83rd Annual Meeting of The Endocrine Society","article-title":"HIV-1 accessory protein Vpr antagonizes insulin\u2019s effect on the cytosolic translocation of FKHR and promotes its transcriptional activity: potential contribution of Vpr to insulin resistance of AIDS patients","author":"Kino","year":"2001"},{"key":"10.4158\/EP.7.6.480_bb0200","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/emboj\/19.5.989","article-title":"Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR","volume":"19","author":"Nakae","year":"2000","journal-title":"EMBO J."},{"key":"10.4158\/EP.7.6.480_bb0205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/N2YQA278NTB3EVUA.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:41:28Z","timestamp":1761514888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20393101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S1530891X20393101"],"URL":"https:\/\/doi.org\/10.4158\/ep.7.6.480","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired Immunodeficiency Syndrome-Related Insulin Resistance and Lipodystrophy: A Multifactorial Viral and Iatrogenic Condition","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.7.6.480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}